OptiBiotix Health Plc (OPTI.L)
- Previous Close
17.75 - Open
18.00 - Bid 17.50 x --
- Ask 18.00 x --
- Day's Range
17.50 - 18.00 - 52 Week Range
5.57 - 43.49 - Volume
17,409 - Avg. Volume
282,799 - Market Cap (intraday)
17.385M - Beta (5Y Monthly) 1.58
- PE Ratio (TTM)
-- - EPS (TTM)
-0.15 - Earnings Date Jun 26, 2024 - Jul 1, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
OptiBiotix Health Plc, a life sciences company, engages in the discovery and development of microbiome modulators primarily in the United Kingdom. The company identifies and develops microbial strains, compounds, and formulations for use in food ingredients, supplements, and active compounds that impacts human physiology deriving potential health benefits. Its products include Slimbiome, a natural ingredient, which offers a healthy and hunger-free weight management system; SlimBiome Medical, a natural supplement for weight management; CholBiome, a food supplement for maintaining healthy levels of cholesterol; Lactobacillus plantarum LPLDL, a probiotic that aids elements of cardiovascular and wellbeing; LPGOS, a galactooligosaccharid that is used in food products and applications, which helps in reducing cardiovascular risk factors and enhancing health; and Sweetbiotix, a sweetener for use in food and beverages. The company's products prevents and manages chronic lifestyle diseases, including obesity, hypercholesterolemia, and diabetes. OptiBiotix Health Plc was incorporated in 2006 and is headquartered in York, the United Kingdom.
www.optibiotix.comRecent News: OPTI.L
Performance Overview: OPTI.L
Trailing total returns as of 4/25/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: OPTI.L
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: OPTI.L
Valuation Measures
Market Cap
17.38M
Enterprise Value
16.33M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
24.97
Price/Book (mrq)
1.92
Enterprise Value/Revenue
23.71
Enterprise Value/EBITDA
-1.25
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-8.50%
Return on Equity (ttm)
-85.52%
Revenue (ttm)
689k
Net Income Avi to Common (ttm)
-13.18M
Diluted EPS (ttm)
-0.15
Balance Sheet and Cash Flow
Total Cash (mrq)
893k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-1.36M
Company Insights: OPTI.L
OPTI.L does not have Company Insights